APEX1 promotes transcriptional activation of HIF-1 and its reduced levels are related to a decrease in tumour volume and FDG uptake, suggesting that it affects glucose metabolism and cellular proliferation [41]. The gene discussed is APEX1; the disease is neoplasm.